Status:
TERMINATED
Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Laparotomy
Hepatic Resection
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Intravenous morphine Patient-Controlled analgesia is gold standard on post - operative liver resection. But, opioids tend to be ineffective for pain that is associated with movement and have significa...
Detailed Description
This study is a prospective, double blind, randomized study. Subjects will be randomized using a computer-generated table of random numbers into 2 groups. The patients scheduled to undergo open liver ...
Eligibility Criteria
Inclusion
- ASA I-III
- Scheduled for open hepatic resection
- Patients must be able to understand the IV morphine PCA
- Written informed consent
- Free from pain in preoperative period
Exclusion
- Age \< 18 years
- Severe hepatic
- Renal impairment
- Pregnancy or lactation
- Allergy to one of the specific drugs under study
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01890408
Start Date
November 1 2013
End Date
February 1 2014
Last Update
June 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département anesthésie-réanimation
Paris, France, 75012